Zevra SVP granted RSUs and stock options

Zevra Therapeutics senior vice president of finance and corporate controller Timothy J. Sangiovanni received new equity awards.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Zevra Therapeutics senior vice president of finance and corporate controller Timothy J. Sangiovanni received new equity awards. He was granted 20,000 restricted stock units, each representing one share of common stock, and a stock option for 40,000 shares at an exercise price of $11.40 per share. The option vests in four equal annual installments beginning on March 1, 2027, while the restricted stock units vest one third on March 1, 2027 and the remaining two thirds in equal annual installments thereafter, in each case subject to his continued service.

Insider Trade Summary

Grant/Award: 60,000 shares

Grant/Award 2 txns

Insider Sangiovanni Timothy J.

Role SVP, Finance & Corp Controller

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	40,000	$0.00	$0.00
Grant/Award	Restricted Stock Unit	20,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 40,000 contracts (Direct); Restricted Stock Unit — 20,000 contracts (Direct)

Footnotes (3)

F1. Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on March 1, 2027, subject to the Reporting Person's continued service on such vesting date.
F2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3. The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

Key Figures

Restricted stock units granted: 20,000 units Stock options granted: 40,000 options Option exercise price: $11.40 per share +3 more

6 metrics

Restricted stock units granted 20,000 units Each RSU equals one share of common stock

Stock options granted 40,000 options Option to buy common stock

Option exercise price $11.40 per share Stock option conversion/exercise price

Option vesting start March 1, 2027 Four equal annual installments from this date

RSU initial vesting One third on March 1, 2027 Remaining two thirds vest annually thereafter

Option expiration May 27, 2036 Expiration date of stock option grant

Key Terms

Restricted Stock Unit, Stock Option (right to buy), Amended and Restated 2014 Equity Incentive Plan, vest and settle, +1 more

5 terms

Restricted Stock Unit financial

"Each restricted stock unit represents a contingent right to receive one share"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Stock Option (right to buy) financial

"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan"

Amended and Restated 2014 Equity Incentive Plan financial

"stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan"

vest and settle financial

"The restricted stock units will vest and settle as to one third of the restricted stock units"

exercise price financial

"conversion_or_exercise_price: "11.4000""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did ZEVRA (ZVRA) report for Timothy J. Sangiovanni?

Zevra reported that Timothy J. Sangiovanni received equity awards, not open-market trades. He was granted 20,000 restricted stock units and a stock option covering 40,000 shares of common stock as part of his compensation package.

How many restricted stock units did the ZEVRA (ZVRA) executive receive?

Timothy J. Sangiovanni received 20,000 restricted stock units. Each unit represents a contingent right to receive one share of Zevra’s common stock, subject to the vesting schedule and his continued service with the company through the applicable vesting dates.

What stock option grant was reported for the ZEVRA (ZVRA) SVP of Finance?

He was granted a stock option for 40,000 shares of Zevra common stock at an exercise price of $11.40 per share. The option was issued under the company’s Amended and Restated 2014 Equity Incentive Plan as part of his equity compensation.

When do Timothy J. Sangiovanni’s ZEVRA (ZVRA) stock options vest?

The stock option vests and becomes exercisable in four equal annual installments beginning on March 1, 2027. Each installment is subject to his continued service with Zevra on the relevant vesting date, as described in the Form 4 footnotes.

What is the vesting schedule for ZEVRA (ZVRA) restricted stock units granted?

The restricted stock units vest and settle as to one third on March 1, 2027. The remaining two thirds vest and settle in equal annual installments thereafter, provided Timothy J. Sangiovanni continues his service through each vesting date.

Under which plan were the ZEVRA (ZVRA) equity awards granted?

The stock option grant to Timothy J. Sangiovanni was made under Zevra’s Amended and Restated 2014 Equity Incentive Plan. This plan governs the terms of the option award, including vesting conditions and the right to purchase common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/29/2026 - 04:16 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sangiovanni Timothy J.

(Last)

(First)

(Middle)

C/O ZEVRA THERAPEUTICS, INC.

101 FEDERAL STREET

(Street)

BOSTON

MASSACHUSETTS

02110

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZEVRA THERAPEUTICS, INC. [ ZVRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Finance & Corp Controller

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$11.4	05/28/2026		A		40,000		⁽¹⁾	05/27/2036	Common Stock	40,000	$0	40,000	D
Restricted Stock Unit	⁽²⁾	05/28/2026		A		20,000		⁽³⁾	⁽³⁾	Common Stock	20,000	$0	20,000	D

Explanation of Responses:

1. Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on March 1, 2027, subject to the Reporting Person's continued service on such vesting date.

2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

3. The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

Remarks:

	/s/ Timothy J. Sangiovanni	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR